Australia's Hydration Pharmaceuticals rises on higher quarterly sales

Hydration Pharmaceuticals

19/07/2023 03:26

** Shares of Hydration Pharmaceuticals  HPC.AX  rise as much
as 3.5% to A$0.059, set for best day since June 30, if gains
hold 
    ** The hydration solutions company records unaudited net
sales in Q2 of $2.8 mln, up 24% on the prior year comparative
period
    ** Net sales result achieved with ongoing reduction in
marketing costs, which fell by 27% on the PCP to $0.9 mln
    ** 48-hour sales on Amazon USA and Amazon Canada totalled
over $120,000 on a currency-adjusted basis 

 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com))